Risk of Major Adverse Limb Events and Benefits of Evolocumab in Patients With Peripheral Artery Disease by History of Prior Peripheral Revascularization

被引：1
|
作者：
Nault, Patrice [1 ]
Bonaca, Marc [2 ]
Giugliano, Robert P. [2 ]
Honarpour, Narimon [3 ]
Keech, Anthony C. [4 ]
Sever, Peter S. [5 ]
Pedersen, Terje R. [6 ]
Sabatine, Marc [7 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Harvard Clin Res Inst, Boston, MA USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Univ Sydney, Sydney, NSW, Australia
[5] Imperial Coll London, London, England
[6] Inst Clin Med, Oslo, Norway
[7] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF VASCULAR SURGERY | 2019年 / 69卷 / 06期
关键词：
D O I：
10.1016/j.jvs.2019.04.279
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
RS13
引用
收藏
页码：E195 / E195
页数：1
相关论文
共 50 条
  • [31] Lipoprotein(a) and risk of peripheral arterial disease, abdominal aortic aneurysms, and major adverse limb events
    Thomas, P.
    Vedel-Krogh, S.
    Nielsen, S. F.
    Nordestgaard, B.
    Kamstrup, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [32] Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease
    Ariel Berger
    Alex Simpson
    Nicholas J. Leeper
    Brian Murphy
    Beth Nordstrom
    Windsor Ting
    Qi Zhao
    Jeffrey Berger
    Advances in Therapy, 2020, 37 : 974 - 974
  • [33] Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease
    Wheeler, Matt
    Chan, Noel
    Eikelboom, John
    FUTURE CARDIOLOGY, 2020, 16 (06) : 597 - 612
  • [34] Smoking Intensity and Major Adverse Limb Events Following Infrainguinal Bypass for Symptomatic Peripheral Artery Disease
    Kalbaugh, Corey A.
    Young, Jessica C.
    Paul, Nicole J.
    McGinigle, Katharine L.
    Crowner, Jason
    Pascarella, Luigi
    Farber, Mark A.
    Kibbe, Melina R.
    Marston, William A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E251 - E252
  • [35] Geographic variation in peripheral artery disease and major adverse cardiovascular and limb events among Medicare beneficiaries
    Van't Hof, Jeremy R.
    Oldenburg, Niki C.
    Krzyzanowski, Brittany
    Weinhandl, Eric
    Kne, Len
    Bonaca, Marc P.
    Beckman, Joshua A.
    Comerota, Anthony J.
    Mandic, Pinar Karaca
    VASCULAR MEDICINE, 2018, 23 (03) : 314 - 315
  • [36] Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization
    Desai, Urvi
    Kharat, Akshay
    Hess, Connie N.
    Milenthevic, Dejan
    Laliberte, Francois
    Zuckerman, Peter
    Benson, John
    Lefebvre, Patrick
    Hiatt, William R.
    Bonaca, Marc P.
    ANNALS OF VASCULAR SURGERY, 2021, 75 : 217 - 226
  • [37] Vorapaxar in Patients with Peripheral Artery Disease with or without Previous Limb Revascularization
    Bonaca, Marc P.
    Creager, Mark A.
    Scirica, Benjamin S.
    Murphy, Sabina A.
    Braunwald, Eugene
    Morrow, David A.
    VASCULAR MEDICINE, 2015, 20 (03) : 286 - 287
  • [38] Long-term Cardiovascular and Limb Outcomes and Associations With Major Adverse Limb Events After Peripheral Revascularization
    Hess, Connie N.
    Wang, Tracy Y.
    Fu, Julia Weleski
    Gundrum, Jacob
    LaPointe, Nancy Allen
    Rogers, Robert K.
    Hiatt, William R.
    CIRCULATION, 2019, 140
  • [39] Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease
    Leiva, Orly
    Brunner, Andrew M.
    How, Joan
    Hobbs, Gabriela S.
    Berger, Jeffrey S.
    BLOOD, 2023, 142
  • [40] Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease
    Golledge, Jonathan
    Velu, Ramesh
    Quigley, Frank
    Jenkins, Jason
    Singh, Tejas P.
    ANNALS OF VASCULAR SURGERY, 2022, 78 : 310 - 320
12345